Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Xenon Pharmaceuticals Inc (XENE)

Xenon Pharmaceuticals Inc (XENE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,341,314
  • Shares Outstanding, K 51,589
  • Annual Sales, $ 32,170 K
  • Annual Income, $ -28,840 K
  • 60-Month Beta 1.89
  • Price/Sales 50.36
  • Price/Cash Flow N/A
  • Price/Book 4.96
Trade XENE with:

Options Overview Details

View History
  • Implied Volatility 83.50% ( +4.09%)
  • Historical Volatility 67.22%
  • IV Percentile 26%
  • IV Rank 7.59%
  • IV High 306.23% on 09/14/21
  • IV Low 65.22% on 12/23/21
  • Put/Call Vol Ratio 1.53
  • Today's Volume 124
  • Volume Avg (30-Day) 113
  • Put/Call OI Ratio 1.91
  • Today's Open Interest 128
  • Open Int (30-Day) 1,130

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate -0.42
  • Number of Estimates 5
  • High Estimate -0.29
  • Low Estimate -0.67
  • Prior Year -0.34
  • Growth Rate Est. (year over year) -23.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.60 +10.16%
on 01/24/22
33.02 -17.93%
on 01/19/22
-3.40 (-11.15%)
since 12/23/21
3-Month
23.26 +16.51%
on 12/06/21
36.42 -25.59%
on 11/08/21
-3.76 (-12.18%)
since 10/22/21
52-Week
13.98 +93.81%
on 01/27/21
36.42 -25.59%
on 11/08/21
+11.13 (+69.69%)
since 01/22/21

Most Recent Stories

More News
Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $15.0 Million Regulatory Milestone

BURNABY, British Columbia, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company,...

XENE : 27.10 (+4.23%)
NBIX : 75.86 (+1.01%)
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2022

BURNABY, British Columbia, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company,...

XENE : 27.10 (+4.23%)
Xenon Pharmaceuticals Presents Additional Positive Data from Phase 2b ‘X-TOLE’ Clinical Trial at the Annual Meeting of the American Epilepsy Society (AES 2021)

Topline Data Showed All Primary and Secondary Seizure Reduction Endpoints Statistically Significant Across All Dose Groups, with p-value of

XENE : 27.10 (+4.23%)
Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2021)

BURNABY, British Columbia, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company,...

XENE : 27.10 (+4.23%)
Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences

BURNABY, British Columbia, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company,...

XENE : 27.10 (+4.23%)
Xenon Pharmaceuticals (XENE) Reports Q3 Loss, Tops Revenue Estimates

Xenon Pharmaceuticals (XENE) delivered earnings and revenue surprises of 18.18% and 4.69%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?...

XENE : 27.10 (+4.23%)
Xenon Pharmaceuticals: Q3 Earnings Snapshot

BURNABY, British Columbia (AP) _ Xenon Pharmaceuticals Inc. (XENE) on Wednesday reported a loss of $15.1 million in its third quarter.

XENE : 27.10 (+4.23%)
Xenon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update

XEN1101 X-TOLE Presentations Scheduled at AES 2021 with Planning Underway for Phase 3 Initiation in 2022 Conference Call at 4:30 pm ET Today BURNABY,...

XENE : 27.10 (+4.23%)
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2021 Financial Results and Provide Corporate Update

BURNABY, British Columbia, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company,...

XENE : 27.10 (+4.23%)
Earnings Preview: Xenon Pharmaceuticals (XENE) Q3 Earnings Expected to Decline

Xenon Pharmaceuticals (XENE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

XENE : 27.10 (+4.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of medicines through the application of its proprietary discovery platform, which it refer to as Extreme Genetics. Xenon is developing proprietary product candidates for the treatment of both orphan...

See More

Key Turning Points

3rd Resistance Point 30.68
2nd Resistance Point 28.97
1st Resistance Point 28.03
Last Price 27.10
1st Support Level 25.38
2nd Support Level 23.67
3rd Support Level 22.73

See More

52-Week High 36.42
Fibonacci 61.8% 27.85
Last Price 27.10
Fibonacci 50% 25.20
Fibonacci 38.2% 22.55
52-Week Low 13.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar